<--- Back to Details
First PageDocument Content
Biotechnology / Veltuzumab / Milatuzumab / Labetuzumab / Systemic lupus erythematosus / Yttrium (90Y) clivatuzumab tetraxetan / Humanized antibody / Epratuzumab / Tolerx / Monoclonal antibodies / Anatomy / Medicine
Date: 2013-09-30 13:12:42
Biotechnology
Veltuzumab
Milatuzumab
Labetuzumab
Systemic lupus erythematosus
Yttrium (90Y) clivatuzumab tetraxetan
Humanized antibody
Epratuzumab
Tolerx
Monoclonal antibodies
Anatomy
Medicine

Microsoft Word - IMMUNOMEDICS AWARDED DOD GRANT FOR MILATUZUMAB IN LUPUS.doc

Add to Reading List

Source URL: www.immunomedics.com

Download Document from Source Website

File Size: 22,17 KB

Share Document on Facebook

Similar Documents

Visterra to Present Data at ICAAC on VIS513, its Humanized Monoclonal Antibody That Targets a Conserved Site on the Dengue Virus E Protein ‒ VIS513 engineered to bind and potently neutralize all four serotypes of dengu

Visterra to Present Data at ICAAC on VIS513, its Humanized Monoclonal Antibody That Targets a Conserved Site on the Dengue Virus E Protein ‒ VIS513 engineered to bind and potently neutralize all four serotypes of dengu

DocID: 1v1w4 - View Document

Metadata Specifications: Antibodies Custom	Fields  Common	Fields

Metadata Specifications: Antibodies Custom Fields Common Fields

DocID: 1pqfc - View Document

Importance  Antibodies LINCS Field Name  1:  Required

Importance Antibodies LINCS Field Name 1:  Required

DocID: 1pbqh - View Document

THE UNIVERSITY OF NEW MEXICO COLLEGE OF PHARMACY ALBUQUERQUE, NEW MEXICO ?

THE UNIVERSITY OF NEW MEXICO COLLEGE OF PHARMACY ALBUQUERQUE, NEW MEXICO ?

DocID: 1p32j - View Document

Poster LFB AACR bis:Mise en page:09 Page1  Towards a new targeted therapy for ovarian cancer: development of an anti-human müllerian inhibiting substance type II receptor humanized antibody Alexandra Jacqu

Poster LFB AACR bis:Mise en page:09 Page1 Towards a new targeted therapy for ovarian cancer: development of an anti-human müllerian inhibiting substance type II receptor humanized antibody Alexandra Jacqu

DocID: 1d8zz - View Document